GlassScriptPhysician profile
Christopher Michael Treat
NPI 1558771618
$21,923.01
in general payments reported to CMS, 2019-2025
22 companies · $12K in 2025
The $12K reported for 2025 was more than what 93% of Hand Surgery providers received nationally (typical 2025 total: $270).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,205 · 2020: $126 · 2021: $1,461 · 2022: $288 · 2023: $218 · 2024: $6,937 · 2025: $12K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $15K · Food and Beverage: $2,396 · Travel and Lodging: $1,341.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $15,105.00 |
| Food and Beverage | $2,396.45 |
| Travel and Lodging | $1,341.36 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $9,799.63 | 2019-2025 | Tapestry |
| Trice Medical, INC. | $9,017.44 | 2023-2025 | |
| Arthrex, INC. | $1,313.16 | 2021 | |
| Smith+Nephew, INC. | $504.76 | 2019-2025 | Bioinductive Implant With Arthroscopic Delivery System - Medium, Bone Anchors With Arthroscopic Delivery System, Accu-Pass |
| Stryker Corporation | $449.05 | 2019-2025 | Hydroset, Gamma, Allowrap |
| Davol INC. | $227.60 | 2021-2025 | Arista |
| Ethicon US, LLC | $146.80 | 2024 | Stratafix, Vistaseal, Dermabond Prineo |
| Baxter Healthcare | $111.39 | 2025 | Perclot, Tisseel |
| Vertex Pharmaceuticals Incorporated | $60.37 | 2025 | |
| Anika Therapeutics, INC. | $51.39 | 2025 | Integrity Implant |
| Pylant Medical | $31.93 | 2022 | |
| Endo Pharmaceuticals INC. | $30.10 | 2021-2023 | Xiaflex |
| Dynasplint Systems INC. | $28.21 | 2025 | Dynasplint |
| Becton, Dickinson and Company | $25.39 | 2022 | |
| Bioventus LLC | $20.01 | 2020 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Daiichi Sankyo INC. | $19.91 | 2019 | |
| Kls-Martin L.P. | $17.12 | 2019 | |
| Pacira Therapeutics, INC. | $15.25 | 2020 | |
| Kci USA, INC. | $14.82 | 2019 | |
| Sanofi-Aventis U.S. LLC | $14.70 | 2019 | |
| Zyla Life Sciences, INC. | $14.39 | 2019 | |
| Alafair Biosciences, INC. | $9.59 | 2024 | Versawrap |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Treat listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.